Kennedy Eugene P. 4

Accession 0001126234-19-000107

CIK 0001126234other

View on SEC.gov Company Profile

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 6:40 PM ET

Size

64.6 KB

Accession

0001126234-19-000107

Insider Transaction Report

Form 4

Period: 2019-07-31

NEWLINK GENETICS CORP(NLNK)

Kennedy Eugene P.

Chief Medical Officer

Transactions

Award
Stock Option (Right to Buy)
2019-07-31+73→ 73 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (73 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+16,667→ 16,667 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (16,667 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+15,625→ 15,625 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (15,625 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+11,944→ 11,944 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (11,944 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2019-07-31−30,000→ 0 total
Exercise: $30.48From: 2015-03-11Exp: 2024-03-10→ Common Stock (30,000 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+2,326→ 2,326 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (2,326 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+313→ 313 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (313 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+2,525→ 2,525 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (2,525 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+241→ 241 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (241 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+250→ 250 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (250 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2019-07-31+50,000→ 0 total
Exercise: $22.85From: 2015-01-07Exp: 2024-01-06→ Common Stock (50,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2019-07-31−1,000→ 0 total
Exercise: $7.73From: 2017-08-13Exp: 2027-07-12→ Common Stock (1,000 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+177→ 177 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (177 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+7,032→ 7,032 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (7,032 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2019-07-31−10,000→ 0 total
Exercise: $39.05From: 2016-01-20Exp: 2025-01-19→ Common Stock (10,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2019-07-31−50,000→ 0 total
Exercise: $10.78From: 2016-09-09Exp: 2026-08-08→ Common Stock (50,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2019-07-31−50,000→ 0 total
Exercise: $10.55From: 2017-02-03Exp: 2027-01-02→ Common Stock (50,000 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2019-07-31−50,000→ 0 total
Exercise: $15.33From: 2014-05-10Exp: 2023-05-09→ Common Stock (50,000 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+4,724→ 4,724 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (4,724 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+469→ 469 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (469 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+174→ 174 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (174 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2019-07-31−10,000→ 0 total
Exercise: $46.73From: 2016-06-23Exp: 2025-06-22→ Common Stock (10,000 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+2,188→ 2,188 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (2,188 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2019-07-31−12,641→ 0 total
Exercise: $34.73From: 2016-02-04Exp: 2026-01-03→ Common Stock (12,641 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+330→ 330 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (330 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+66→ 66 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (66 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+24,306→ 24,306 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (24,306 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+695→ 695 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (695 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+4,550→ 4,550 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (4,550 underlying)
Award
Stock Option (Right to Buy)
2019-07-31+4,826→ 4,826 total
Exercise: $1.77Exp: 2026-07-31→ Common Stock (4,826 underlying)

Footnotes (5)

[F1]On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program. In exchange, for every three cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share.
[F2]The option vests as to 50% on the first anniversary of grant date and the remaining 50% on the second anniversary of grant date.
[F3]On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program. In exchange, for every four cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share.
[F4]The option vests as to 50% on the second anniversary of grant date and the remaining 50% on the third anniversary of grant date.
[F5]On July 31, 2019, the issuer cancelled this option grant pursuant to the issuer's option exchange program. In exchange, for every two cancelled options, the reporting person received a replacement option having an exercise price of $1.77 per share.

Documents

1 file

4
wf-form4_156478560283213.xmlPrimary
FORM 4

Issuer

NEWLINK GENETICS CORP

CIK 0001126234

→

Entity typeother

Related Parties

filerCIK 0001721685

Filing Metadata

Form type: 4
Filed: Aug 1, 8:00 PM ET
Accepted: Aug 2, 6:40 PM ET
Size: 64.6 KB

View on SEC.gov